Reni J. Benjamin
Stock Analyst at Citizens
(3.14)
# 1,226
Out of 5,055 analysts
12
Total ratings
40%
Success rate
8.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Reni J. Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Maintains: Market Outperform | $348 → $396 | $365.82 | +8.25% | 1 | Nov 7, 2025 | |
| SANA Sana Biotechnology | Maintains: Market Outperform | $5 → $8 | $3.99 | +100.50% | 1 | Oct 30, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Market Outperform | $40 | $18.03 | +121.85% | 3 | Oct 20, 2025 | |
| KURA Kura Oncology | Reiterates: Market Outperform | $24 | $11.21 | +114.19% | 2 | Oct 20, 2025 | |
| INBX Inhibrx Biosciences | Reiterates: Market Perform | n/a | $79.13 | - | 1 | Aug 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Market Outperform | $4 → $3 | $0.92 | +226.73% | 1 | Aug 21, 2025 | |
| PRLD Prelude Therapeutics | Maintains: Market Outperform | $4 → $3 | $1.52 | +97.37% | 1 | Aug 18, 2025 | |
| BCAB BioAtla | Downgrades: Market Perform | n/a | $0.79 | - | 1 | Aug 13, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Market Outperform | $22 → $10 | $6.50 | +53.85% | 1 | Aug 12, 2025 |
BeOne Medicines AG
Nov 7, 2025
Maintains: Market Outperform
Price Target: $348 → $396
Current: $365.82
Upside: +8.25%
Sana Biotechnology
Oct 30, 2025
Maintains: Market Outperform
Price Target: $5 → $8
Current: $3.99
Upside: +100.50%
Summit Therapeutics
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $40
Current: $18.03
Upside: +121.85%
Kura Oncology
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $24
Current: $11.21
Upside: +114.19%
Inhibrx Biosciences
Aug 22, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $79.13
Upside: -
Werewolf Therapeutics
Aug 21, 2025
Maintains: Market Outperform
Price Target: $4 → $3
Current: $0.92
Upside: +226.73%
Prelude Therapeutics
Aug 18, 2025
Maintains: Market Outperform
Price Target: $4 → $3
Current: $1.52
Upside: +97.37%
BioAtla
Aug 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $0.79
Upside: -
Bicycle Therapeutics
Aug 12, 2025
Maintains: Market Outperform
Price Target: $22 → $10
Current: $6.50
Upside: +53.85%